| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009908859 |
| P356 | DOI | 10.1007/S00247-010-1876-3 |
| P698 | PubMed publication ID | 20978754 |
| P2093 | author name string | Rakesh Kumar | |
| Vishnubhatla Sreenivas | |||
| Mehar Chand Sharma | |||
| Shah Alam Khan | |||
| Shishir Rastogi | |||
| Jyoti Bajpai | |||
| Arun Malhotra | |||
| Sameer Bakhshi | |||
| Shivanand Gamnagatti | |||
| Rajni Safaya | |||
| P2860 | cites work | Reporting results of cancer treatment | Q29620070 |
| Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors | Q30620964 | ||
| Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging | Q30777038 | ||
| Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy | Q30983132 | ||
| The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome | Q31043513 | ||
| Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. | Q31049725 | ||
| Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. | Q31065612 | ||
| Diffusion-weighted MRI in the body: applications and challenges in oncology | Q31113294 | ||
| Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma | Q33433095 | ||
| Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response | Q34659387 | ||
| Anti-cancer drugs of today and tomorrow: are we close to making the turn from treating to curing cancer? | Q34779987 | ||
| Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. | Q35753761 | ||
| Pharmacokinetic studies in children with cancer | Q35975322 | ||
| Diagnostic architectural and dynamic features at breast MR imaging: multicenter study | Q36350990 | ||
| Modeling growth kinetics and statistical distribution of oligometastases | Q36431601 | ||
| Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. | Q38526138 | ||
| Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities. | Q41731927 | ||
| Initial tumor size predicts histologic response and survival in localized osteosarcoma patients | Q44327301 | ||
| DCE-MRI pixel-by-pixel quantitative curve pattern analysis and its application to osteosarcoma | Q46697285 | ||
| Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity | Q47406086 | ||
| Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas | Q47760998 | ||
| Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma. | Q53555897 | ||
| Osteosarcoma | Q57991188 | ||
| Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging | Q61903856 | ||
| Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter | Q68780653 | ||
| Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor | Q69842508 | ||
| A system for the surgical staging of musculoskeletal sarcoma | Q71433572 | ||
| Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET | Q71493937 | ||
| Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival | Q72532464 | ||
| Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results | Q80112862 | ||
| Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients | Q80418923 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 441-450 | |
| P577 | publication date | 2010-10-27 | |
| P1433 | published in | Pediatric Radiology | Q7159214 |
| P1476 | title | Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis | |
| P478 | volume | 41 |
| Q55362893 | 18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma. |
| Q64109297 | A giant cell rich osteosarcoma of the proximal ulnar bone treated by elbow arthroplasty: A case report |
| Q35538160 | A new relative tumor sizing method in epi-metaphyseal osteosarcoma |
| Q36750627 | Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. |
| Q48643691 | Clinico-pathological Study of Limb Salvage Surgery for Osteosarcoma: Experience in a Rural Cancer Center |
| Q35072927 | Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy |
| Q31037179 | Diffusion MRI in early cancer therapeutic response assessment |
| Q38845267 | Diffusion-weighted imaging in pediatric body magnetic resonance imaging |
| Q53074113 | Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI. |
| Q91949909 | Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study |
| Q47367714 | Fractal and Gray Level Cooccurrence Matrix Computational Analysis of Primary Osteosarcoma Magnetic Resonance Images Predicts the Chemotherapy Response. |
| Q98771175 | Immune Landscape of the Tumor Microenvironment Identifies Prognostic Gene Signature CD4/CD68/CSF1R in Osteosarcoma |
| Q30998504 | MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report |
| Q43376071 | Meta-Analysis of the Correlation between Apparent Diffusion Coefficient and Standardized Uptake Value in Malignant Disease. |
| Q64071517 | Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings |
| Q49215771 | Necrosis of osteosarcoma cells induces the production and release of high-mobility group box 1 protein |
| Q31133212 | Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: an initial in vivo study |
| Q91630104 | Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center |
| Q34993781 | Positron emission tomography/computed tomography for bone tumors (Review). |
| Q90186912 | Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T |
| Q53026369 | Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT. |
| Q33800218 | Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells |
| Q92615942 | Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in prediction of response to neoadjuvant chemotherapy in pediatric osteosarcoma |
| Q41810446 | Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI. |
| Q45224642 | Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome. |
| Q26752425 | UK guidelines for the management of bone sarcomas |
| Q64088483 | Utility of Multi-Parametric Quantitative Magnetic Resonance Imaging for Characterization and Radiotherapy Response Assessment in Soft-Tissue Sarcomas and Correlation With Histopathology |
| Q60432978 | Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results |
| Q39419807 | Value of diffusion-weighted imaging for evaluating chemotherapy response in osteosarcoma: A meta-analysis |
Search more.